| 7.42 Data as of 1:04pm ET | -0.08 / -1.07%Today’s Change | 3.77 Today|||52-Week Range 11.88 | -17.74% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $518.5M |
Company Description
Synta Pharmaceuticals Corp. is a biopharmaceutical company. It focuses on discovering, developing and commercializing novel pharmaceutical products for extending and enhancing the lives of patients with severe medical conditions, which include cancer and chronic inflammatory disease. The company has a chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical and preclinical-stage drug candidates with mechanisms of action and novel chemical structures. It was founded by Safi R. Bahcall and Lan-Bo Chen in July 2001 and is headquartered in Lexington, MA.
Employees

Shareholders
| Individual stakeholders | 35.13% |
| Other institutional | 23.19% |
| Mutual fund holders | 17.53% |
Top Executives
| Safi R. Bahcall, PhD | President, Chief Executive Officer & Director |
| Keith S. Ehrlich, MBA, CPA | Chief Financial Officer & VP-Administration |
| Iman El-Hariry, MD, PhD | Vice President-Clinical Research |
| Sumant Ramachandra, MD, PhD | President-Research & Development |
| Vojo Vukovic, MD, PhD | Chief Medical Officer & Senior Vice President |